Breaking News

Over a week ago
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

, GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

07:58
06/12/17
06/12
07:58
06/12/17
07:58
Recommendations
Zynerba, GW Pharmaceuticals analyst commentary at Maxim »

Zynerba an…

ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

GWPH

GW Pharmaceuticals

$94.99

0.85 (0.90%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Jun

ZYNE

Zynerba

$18.20

-0.18 (-0.98%)

16:38
06/09/17
06/09
16:38
06/09/17
16:38
Syndicate
Breaking Syndicate news story on Zynerba »

Zynerba files $250M mixed…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ZYNE

Zynerba

$18.77

0.24 (1.30%)

07:52
06/08/17
06/08
07:52
06/08/17
07:52
Hot Stocks
Zynerba achieves target enrollment in trial evaluating ZYN002 »

Zynerba Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Jun

Over a month ago
ZYNE

Zynerba

$19.75

0.51 (2.65%)

07:59
05/09/17
05/09
07:59
05/09/17
07:59
Hot Stocks
Zynerba reports cash and equivalents $77.5M as of March 31 »

As of March 31 cash and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ZYNE

Zynerba

$19.75

0.51 (2.65%)

07:58
05/09/17
05/09
07:58
05/09/17
07:58
Earnings
Zynerba reports Q1 EPS (60c), consensus (55c) »

Reports Q1 revenue $0,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ZYNE

Zynerba

$21.86

0.88 (4.19%)

04:55
05/02/17
05/02
04:55
05/02/17
04:55
Conference/Events
Zynerba management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 06

    Jun

ZYNE

Zynerba

$20.98

-0.01 (-0.05%)

12:06
05/01/17
05/01
12:06
05/01/17
12:06
Conference/Events
Zynerba management to meet with Jefferies »

Meeting to be held in San…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    May

  • 06

    Jun

ZYNE

Zynerba

$19.96

-0.06 (-0.30%)

07:22
03/31/17
03/31
07:22
03/31/17
07:22
Recommendations
Zynerba analyst commentary at Oppenheimer »

Oppenheimer remains…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ZYNE

Zynerba

$21.16

1.51 (7.68%)

07:12
03/28/17
03/28
07:12
03/28/17
07:12
Recommendations
Zynerba analyst commentary at H.C. Wainwright »

Zynerba price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ZYNE

Zynerba

$19.65

0.02 (0.10%)

06:32
03/27/17
03/27
06:32
03/27/17
06:32
Earnings
Breaking Earnings news story on Zynerba »

Zynerba reports Q4 EPS…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Mar

  • 06

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.